期刊文献+

步长脑心通在原发性高血压病中的运用及对C反应蛋白、一氧化氮的影响 被引量:3

The influence of C-reactive protein and nitric oxide in the patients of essential hypertension used Naoxintong
下载PDF
导出
摘要 目的观察步长脑心通在原发性高血压病中的运用及对C反应蛋白(CRP)和一氧化氮(NO)的影响,探讨脑心通的作用机制。方法 120例原发性高血压病患者随机分为常规治疗组(n=60)及脑心通组(n=60)。常规治疗组应用降压药物治疗使血压控制在140/90 mmHg以下。不使用其他调脂、抗氧化药物、非类固醇类消炎镇痛药物;脑心通组在常规治疗基础上加用步长脑心通胶囊,疗程为4周。治疗前后测定CRP、NO。结果经治疗后CRP均有下降,NO均明显升高,脑心通组与常规治疗组比较,变化更明显(P<0.05)。结论步长脑心通胶囊治疗原发性高血压通过降低CRP水平,提高NO水平而起到抑制炎症,改善内皮功能等作用,对预防脑血栓形成是有效、安全的治疗手段。 OBJECTIVE To observe the influence of C-reactive protein(CRP) and nitric oxide(NO)in the patients of essential hypertension used Naoxintong,and to explore Naoxintong mechanism of action.METHODS 120 patients with primary hypertension were randomly assigned to conventional therapy group(n=60)and Naoxintong group(n=60).Conventional treatment group used antihypertensive drug to control blood pressure below 140/90 mmHg.Without used other lipid-lowering,antioxidant drugs,non-steroidal anti-inflammatory drugs.Naoxintong group added Naoxintong besides the antihypertensive drug.Treatment for 4 weeks.Before and after treatment measured C-reactive protein(CRP)and nitric oxide(NO).RESULTS After treatment,CRP decreased and NO obviously elevates in conventional therapy group and Naoxintong group.Naoxintong group compared with the conventional treatment group,the change is more obvious(P0.05).CONCLUSION Naoxintong treatment of essential hypertension inhibits inflammation and improves endothelial function by lowering CRP levels,increased NO levels.Prevention of cerebral thrombosis is effective and safe treatment.
出处 《海峡药学》 2011年第4期91-92,共2页 Strait Pharmaceutical Journal
关键词 步长脑心通 原发性高血压 C反应蛋白 一氧化氮 Naoxintong Essential hypertension C-reactive protein Nitric oxide
  • 相关文献

参考文献5

二级参考文献50

  • 1王鸿利,宋善俊.分子标志物在诊断血栓前状态的意义[J].国外医学(输血及血液学分册),1995,18(2):68-72. 被引量:67
  • 2孙传兴.临床疾病诊断依据治愈好转标准[M].北京:人民军医出版社,1998.458.
  • 3Jenkins GM, Crow T, Bilato C et al. Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of ballon-injured rat carotid arteries. Circulation, 1998; 97: 82~90
  • 4Shu YE, Steve H, Adriano H et al. Matrix metalloproteinases: implication in vascular matrix remodeling during atherogenesis. Clin Sci, 1998; 94: 103~110
  • 5Diane CC, William HF. Matrix metalloproteinases and coronary artery disease: a novel therapeutic target. J Clin Pharmacol, 1997; 38: 991~1000
  • 6Liu YE, Wang M, Greene J et al. Preparation and characterization of recombination Timp-4. J Bio Chem, 1997; 272: 20479~20483
  • 7Bigg HF, Shi YE, Liu Ye et al. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4(TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A: TIMP-4 binds progelatinase A and the COOH-terminal in a similar manner to TIMP-2. J Biol Chem, 1997; 272: 15496~15550
  • 8Baker AH, Zaltsman AB, George SJ et al. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. Timp-3 promotes apoptosis. J Clin Invest, 1998; 101: 1478~1487
  • 9Hiroyasu U, Jong DL, Hiromasa S et al. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Arterosclerosis, 2000; 149: 51~59
  • 10Elaine L, Douglas EV, Smruti HP et al. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res, 1996; 78: 44~49

共引文献80

同被引文献47

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部